These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38802999)

  • 1. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA.
    Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P
    Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999
    [No Abstract]   [Full Text] [Related]  

  • 2. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.
    Wang Y; Huang X; Chen S; Jiang H; Rao H; Lu L; Wen F; Pei J
    Curr Oncol; 2022 Sep; 29(9):6573-6593. PubMed ID: 36135086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel prognostic signature composed of 3 cuproptosis-related transcription factors in colon adenocarcinoma.
    Zhou L; Zhang Y; Xu Y; Jiang T; Tang L
    Genes Genomics; 2023 Aug; 45(8):1047-1061. PubMed ID: 37318704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
    Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
    Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 65‑gene signature for prognostic prediction in colon adenocarcinoma.
    Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B
    Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis-related molecular classification and gene signature of hepatocellular carcinoma and experimental verification.
    Chen Z; Du D; Li J; Zhang W; Shao J
    Transl Cancer Res; 2024 Mar; 13(3):1268-1289. PubMed ID: 38617510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
    Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
    Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-expression Network Analysis Identified COL8A1 Is Associated with the Progression and Prognosis in Human Colon Adenocarcinoma.
    Shang J; Wang F; Chen P; Wang X; Ding F; Liu S; Zhao Q
    Dig Dis Sci; 2018 May; 63(5):1219-1228. PubMed ID: 29497907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma.
    Zhao QQ; Jiang C; Gao Q; Zhang YY; Wang G; Chen XP; Wu SB; Tang J
    J Cell Physiol; 2020 May; 235(5):4902-4912. PubMed ID: 31709538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Molecular Subtyping Scheme Based on In Silico Analysis of Cuproptosis Regulator Gene Patterns Optimizes Survival Prediction and Treatment of Hepatocellular Carcinoma.
    Jiang H; Chen H; Wang Y; Qian Y
    J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of extracellular matrix-related biomarkers in colon adenocarcinoma by bioinformatics and experimental validation.
    Yin Y; Yang X; Cheng Z; Wang H; Lei J; Wang D; Wang P; Li B; Mi J; Yuan Q
    Front Immunol; 2024; 15():1371584. PubMed ID: 38694509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
    Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
    J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatic analysis and experimental validation of six cuproptosis-associated genes as a prognostic signature of breast cancer.
    Chen X; Sun H; Yang C; Wang W; Lyu W; Zou K; Zhang F; Dai Z; He X; Dong H
    PeerJ; 2024; 12():e17419. PubMed ID: 38912044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of an Immune-Related Prognostic Signature for Ovarian Cancer Based on Weighted Gene Coexpression Network Analysis.
    An Y; Yang Q
    Biomed Res Int; 2020; 2020():7594098. PubMed ID: 33381581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma.
    Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H
    Front Immunol; 2021; 12():769685. PubMed ID: 35003085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of gene modules and hub genes in colon adenocarcinoma associated with pathological stage based on WGCNA analysis.
    Wang H; Liu J; Li J; Zang D; Wang X; Chen Y; Gu T; Su W; Song N
    Cancer Genet; 2020 Apr; 242():1-7. PubMed ID: 32036224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA.
    Ling X; Zhang L; Fang C; Liang H; Zhu J; Ma J
    Transl Lung Cancer Res; 2023 Apr; 12(4):754-769. PubMed ID: 37197625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma.
    Peng X; Zhu J; Liu S; Luo C; Wu X; Liu Z; Li Y; Yuan R
    Front Immunol; 2022; 13():990790. PubMed ID: 36248822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.